☆ 4.7 Article

Glycemic Control and Clinical Outcomes in US Patients With COVID-19: Data From the National COVID Cohort Collaborative (N3C) Database

DIABETES CARE (2022)

Related references

Note: Only part of the references are listed.

Review Endocrinology & Metabolism

Elevated HbA1c levels in pre-Covid-19 infection increases the risk of mortality: A sistematic review and meta-analysis

Francesco Prattichizzo et al.

Summary: This meta-analysis aimed to explore the impact of HbA1c values at hospital pre-admission or at-admission on COVID-19 mortality or worsening in patients with diabetes. The results from seven observational studies showed that HbA1c was linearly associated with increased risk of COVID-19 mortality or worsening, especially in patients with poor glycaemic control.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2022)

Add to Collection

Article Endocrinology & Metabolism

Haemoglobin A1c is a predictor of COVID-19 severity in patients with diabetes

Eugene Merzon et al.

Summary: The study found an association between pre-infection HbA1c levels and COVID-19 severity in diabetic patients, with higher HbA1c levels indicating a greater risk of hospitalization. The importance of pre-infection risk stratification for successful disease management, resource allocation, and reducing economic and social burden was emphasized.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2021)

Add to Collection

Article Endocrinology & Metabolism

Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes

Andrew B. Crouse et al.

Summary: The study found that Black/African-Americans, obesity, hypertension, and diabetes were associated with higher likelihood of contracting COVID-19. Diabetes was also linked to a dramatic increase in COVID-19-related mortality, but the use of metformin showed a significant reduction in mortality for diabetic individuals with COVID-19.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Article Virology

Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity

Carolyn T. Bramante et al.

Summary: Observational studies indicate that outpatient metformin use may reduce mortality from COVID-19, but the impact on hospitalization rates remains uncertain.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland

Stuart J. McGurnaghan et al.

Summary: The study aimed to compare the risk of fatal or critical care unit-treated COVID-19 between people with and without diabetes, and developed a predictive model. Results showed that people with diabetes had a higher risk of developing the disease, with several related factors, and the predictive model demonstrated good accuracy.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Racial and Ethnic Disparities in SARS-CoV-2 Testing and COVID-19 Outcomes in a Medicaid Managed Care Cohort

Mireille Jacobson et al.

Summary: The study revealed that in a local medical center in Northern California, Latino patients were more likely than White patients to receive SARS-CoV-2 testing, be hospitalized, and die from COVID-19. Racial and ethnic disparities varied depending on the local context.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2021)

Add to Collection

Article Endocrinology & Metabolism

Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes

Anna R. Kahkoska et al.

Summary: The study found that the use of GLP1-RA and SGLT2i medications in SARS-CoV-2-positive adults was associated with lower odds of mortality and other adverse outcomes compared to DPP4i users, who were generally older and sicker.

DIABETES CARE (2021)

Add to Collection

Article Multidisciplinary Sciences

Both high and low pre-infection glucose levels associated with increased risk for severe COVID-19: New insights from a population-based study

Michal Shauly-Aharonov et al.

Summary: This study indicates that elevated pre-infection blood glucose is a risk factor for severe COVID-19, even in non-diabetic individuals. For patients with diabetes, both high and low pre-infection glucose levels are risk factors for severe COVID-19. Further research is needed to determine if these associations are causal, but these findings can already have clinical implications for COVID-19 risk assessment and stratification.

PLOS ONE (2021)

Add to Collection

Article Medicine, General & Internal

Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative

Tellen D. Bennett et al.

Summary: The study evaluated COVID-19 severity and risk factors in over 1.9 million US adults, finding that machine learning models can accurately predict clinical severity. It also observed a decrease in COVID-19 mortality over time in 2020 and identified associations between patient demographic characteristics and comorbidities with higher clinical severity.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Infectious Diseases

Unusually High Risks of COVID-19 Mortality with Age-Related Comorbidities: An Adjusted Meta-Analysis Method to Improve the Risk Assessment of Mortality Using the Comorbid Mortality Data

Andrew Antos et al.

Summary: This study re-evaluated mortality data from the US related to COVID-19, incorporating a control group without comorbidity to estimate odds ratios of death by major comorbidities. The results showed that having at least one comorbidity increased the risk of mortality 1113 times higher than having no comorbidity, with hypertension, diabetes, cardiovascular disease, and chronic kidney disease being the top four comorbidities associated with significantly higher odds ratios.

INFECTIOUS DISEASE REPORTS (2021)

Add to Collection

Review Public, Environmental & Occupational Health

The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: A systematic review and meta-analysis

Roshan Kumar Mahat et al.

Summary: This paper conducted a systematic review and meta-analysis on the association of inflammatory parameters with severity and mortality in COVID-19 patients. The results showed significant differences in levels of certain inflammatory parameters between severe and non-severe COVID-19 patients, as well as between non-survivor and survivor groups.

CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH (2021)

Add to Collection

Article Computer Science, Information Systems

The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment

Melissa A. Haendel et al.

Summary: N3C is an open science community focused on analyzing patient-level data from multiple centers to address the challenges posed by COVID-19. By overcoming technical, regulatory, policy, and governance barriers, N3C has successfully established a secure data enclave for efficient, transparent, and reproducible collaborative analytics.

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2021)

Add to Collection

Review Endocrinology & Metabolism

COVID-19 and diabetes mellitus: from pathophysiology to clinical management

Soo Lim et al.

Summary: Initial studies have shown that patients with diabetes mellitus have a higher risk of severe COVID-19, potentially due to hyperglycaemia affecting immune and inflammatory responses. Further investigation is needed to determine the optimal management for patients with diabetes mellitus during the ongoing pandemic.

NATURE REVIEWS ENDOCRINOLOGY (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis

Pan Luo et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)

Add to Collection

Article Cell Biology

Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes

Lihua Zhu et al.

CELL METABOLISM (2020)

Add to Collection

Article Endocrinology & Metabolism

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Bertrand Cariou et al.

DIABETOLOGIA (2020)

Add to Collection

Article Endocrinology & Metabolism

Diabetes and COVID-19: Risks, Management, and Learnings From Other National Disasters

Jamie Hartmann-Boyce et al.

DIABETES CARE (2020)

Add to Collection

Article Endocrinology & Metabolism

Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019

Shivani Agarwal et al.

DIABETES CARE (2020)

Add to Collection

Article Endocrinology & Metabolism

Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients

Zhenzhou Wang et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2020)

Add to Collection

Article Endocrinology & Metabolism

COVID-19 in people with diabetes: understanding the reasons for worse outcomes

Matteo Apicella et al.

LANCET DIABETES & ENDOCRINOLOGY (2020)

Add to Collection

Article Endocrinology & Metabolism

Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study

Naomi Holman et al.

LANCET DIABETES & ENDOCRINOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

Add to Collection

Article Endocrinology & Metabolism

Impact of glycemic control in diabetes mellitus on management of COVID-19 infection

Sudhir Bhandari et al.

INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES (2020)

Add to Collection

Review Public, Environmental & Occupational Health

Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis

Md Mostaured Ali Khan et al.

JOURNAL OF GLOBAL HEALTH (2020)

Add to Collection

Article Critical Care Medicine

125: The Association Between HbA1C and Outcomes in COVID-19 Patients

Pamir Mateen et al.

CRITICAL CARE MEDICINE (2020)

Add to Collection

Review Medicine, General & Internal

Possible Correlations between Atherosclerosis, Acute Coronary Syndromes and COVID-19

Oliwia Grzegorowska et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Article Endocrinology & Metabolism

Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

Bruce Bode et al.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2020)

Add to Collection

Article Endocrinology & Metabolism

Inflammatory markers and control of type 2 diabetes mellitus

Hanan Elimam et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)

Add to Collection

Article Endocrinology & Metabolism

Association between Inflammation and Biological Variation in Hemoglobin A1c in US Nondiabetic Adults

Shuqian Liu et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Add to Collection

Article Public, Environmental & Occupational Health

Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries

Hude Quan et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)

Add to Collection

Article Endocrinology & Metabolism

Influence of Duration of Diabetes, Glycemic Control, and Traditional Cardiovascular Risk Factors on Early Atherosclerotic Vascular Changes in Adolescents and Young Adults with Type 2 Diabetes Mellitus

Amy S. Shah et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)

Add to Collection

Article Medicine, General & Internal

10-year follow-up of intensive glucose control in type 2 diabetes

Rury R. Holman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Add to Collection

Review Cardiac & Cardiovascular Systems

Diabetes and vascular disease -: Pathophysiology, clinical consequences, and medical therapy:: Part I

MA Creager et al.

CIRCULATION (2003)

Add to Collection

Article Medicine, General & Internal

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

IM Stratton et al.

BMJ-BRITISH MEDICAL JOURNAL (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.